PlainRecalls
FDA Drug Critical Class I Terminated

DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0

Reported: August 26, 2020 Initiated: July 21, 2020 #D-1504-2020

Product Description

DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0

Reason for Recall

Superpotent Drug

Details

Units Affected
15,175 nasal sprays
Distribution
Nationwide within the United States.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0. Recalled by Ferring Pharmaceuticals Inc. Units affected: 15,175 nasal sprays.
Why was this product recalled?
Superpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2020. Severity: Critical. Recall number: D-1504-2020.